NCT00929110 · Interventional trial
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)
Overall registry status Completed
Phase 3
Conditions Chronic Obstructive Pulmonary Disease
Delaware Valley sites
- Novartis Investigative Site · Downingtown, PA · Chester County
- Novartis Investigative Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory